Sound Income Strategies’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,592
Closed -$58.1K 1756
2026
Q1
$58.1K Sell
1,592
-199
-11% -$9.43K ﹤0.01% 768
2025
Q4
$112K Sell
1,791
-10
-0.6% -$511 0.01% 554
2025
Q3
$106K Sell
1,801
-891
-33% -$52.2K 0.01% 395
2025
Q2
$186K Buy
2,692
+1,778
+195% +$121K 0.01% 284
2025
Q1
$63.5K Buy
914
+375
+70% +$31K ﹤0.01% 462
2024
Q4
$46.4K Buy
539
+243
+82% +$26.3K ﹤0.01% 481
2024
Q3
$35.3K Sell
296
-828
-74% -$110K ﹤0.01% 523
2024
Q2
$160K Buy
1,124
+1,046
+1,341% +$139K 0.01% 253
2024
Q1
$10K Buy
78
+26
+50% +$3.1K ﹤0.01% 754
2023
Q4
$5.38K Buy
52
+14
+37% +$1.38K ﹤0.01% 881
2023
Q3
$3.46K Sell
38
-2,364
-98% -$208K ﹤0.01% 817
2023
Q2
$194K Buy
2,402
+2,384
+13,244% +$195K 0.02% 150
2023
Q1
$1.43K Hold
18
﹤0.01% 890
2022
Q4
$1.22K Hold
18
﹤0.01% 835
2022
Q3
$1K Hold
18
﹤0.01% 815
2022
Q2
$1K Hold
18
﹤0.01% 828
2022
Q1
$1K Hold
18
﹤0.01% 820
2021
Q4
$1K Hold
18
﹤0.01% 791
2021
Q3
$1K Hold
18
﹤0.01% 771
2021
Q2
$1K Sell
18
-236
-93% -$9.15K ﹤0.01% 812
2021
Q1
$8.56K Hold
254
﹤0.01% 525
2020
Q4
$9K Hold
254
﹤0.01% 477
2020
Q3
$9K Buy
+254
New +$8.47K ﹤0.01% 436
2019
Q3
Sell
-262
Closed -$7K 728
2019
Q2
$7K Hold
262
﹤0.01% 392
2019
Q1
$7K Hold
262
﹤0.01% 398
2018
Q4
$6K Hold
262
﹤0.01% 420
2018
Q3
$6K Hold
262
﹤0.01% 433
2018
Q2
$6K Buy
+262
New +$6.23K ﹤0.01% 401

Other funds holding NVO

Sound Income Strategies's NVO Position: Q2 2026 in Review

Sound Income Strategies sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 1,592 shares — an estimated $58.1K sold.

Sound Income Strategies first reported a position in NVO in Q2 2018 and held it in 28 quarters. The position peaked at $194K in Q2 2023. 1,041 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Sound Income Strategies reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 1,592 Novo Nordisk shares in Q2 2026, an estimated $58.1K.
  • Sound Income Strategies first reported a position in Novo Nordisk in Q2 2018 and held it in 28 quarters.
  • Sound Income Strategies's Novo Nordisk position peaked at $194K in Q2 2023.
  • 1,041 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.